Observational studyFluids and barriers of the CNS2026
Natural killer cells and regulatory T cells in aneurysmal subarachnoid hemorrhage in peripheral blood and cerebrospinal fluid - a pilot study.
Observational study in Fluids and barriers of the CNS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDelayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (SAH) is incompletely understood and may involve intrathecal immune activation. Cytotoxic natural killer (NK) cells can rapidly respond to SAH and promote neuroinflammation, whereas regulatory T cells (Tregs) may counteract excessive immune activation. This study investigates the NK/Treg ratio in cerebrospinal fluid (CSF) and peripheral blood (PB) as a potential immunological marker associated with DCI.
methodsIn this prospective, observational, single-center study, CSF and peripheral blood samples from 21 patients with aneurysmal SAH admitted between 2023 and 2024 were analyzed. Longitudinal dynamics of NK cells and Tregs were assessed by flow cytometry at predefined time points from day 1 to day 14 after hemorrhage. The NK/Treg ratio was calculated for each compartment and time point, and its association with DCI was explored.
resultsTwenty-one patients were included, of whom 16 were female (76.2%). The mean age was 55.9 years (standard deviation [SD] 13.3). Median WFNS and modified Fisher grades at admission were 3 (range 1-5) and 3 (range 1-4), respectively. DCI occurred in 10 patients (47.6%), with a median onset of 8.5 days after hemorrhage (range 4-12). Longitudinal dynamics of NK cells and Tregs in CSF and peripheral blood were assessed using flow cytometry. On day 3, the CSF NK/Treg ratio was higher in patients who later developed DCI compared with patients without DCI (mean 5556.6 [SD 12266.0] vs. 161.8 [SD 195.2]). CSF ratios remained numerically higher at later time points, whereas changes in peripheral blood were modest. In exploratory analyses of clinical covariates, lower modified Fisher grades (1-3 vs. 4) were associated with increased NK/Treg ratios in CSF at day 1 (p = 0.046) and day 2 (p = 0.007), possibly indicating that the elevation was not merely a reflection of subarachnoid blood burden.
conclusionsPatients who developed DCI showed an early intrathecal shift in the balance between NK cells and Tregs, reflected by a higher CSF NK/Treg ratio around day 3. This pattern was more pronounced in CSF than in peripheral blood, suggesting a compartment-specific immune alteration associated with DCI. Although the small sample size, high variability, and limited statistically significant findings preclude definitive conclusions, these data support the hypothesis that early CSF immune dysregulation may contribute to DCI after SAH. CSF-based immune profiling, including the NK/Treg ratio, may therefore represent a promising exploratory approach for DCI risk stratification. Larger prospective multicenter studies with standardized CSF sampling are required to validate these exploratory findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.